FR2291749A1 - Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique - Google Patents

Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique

Info

Publication number
FR2291749A1
FR2291749A1 FR7438204A FR7438204A FR2291749A1 FR 2291749 A1 FR2291749 A1 FR 2291749A1 FR 7438204 A FR7438204 A FR 7438204A FR 7438204 A FR7438204 A FR 7438204A FR 2291749 A1 FR2291749 A1 FR 2291749A1
Authority
FR
France
Prior art keywords
anticholinergic
hypotensive
sedative
hypertensive
analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7438204A
Other languages
English (en)
Other versions
FR2291749B1 (fr
Inventor
Philippe Dostert
Michel Turin
Patrick Guerret
Thierry Imbert
Guy Raynaud
Janine Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Priority to FR7438204A priority Critical patent/FR2291749A1/fr
Publication of FR2291749A1 publication Critical patent/FR2291749A1/fr
Application granted granted Critical
Publication of FR2291749B1 publication Critical patent/FR2291749B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7438204A 1974-11-20 1974-11-20 Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique Granted FR2291749A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7438204A FR2291749A1 (fr) 1974-11-20 1974-11-20 Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7438204A FR2291749A1 (fr) 1974-11-20 1974-11-20 Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2291749A1 true FR2291749A1 (fr) 1976-06-18
FR2291749B1 FR2291749B1 (fr) 1978-07-28

Family

ID=9145106

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7438204A Granted FR2291749A1 (fr) 1974-11-20 1974-11-20 Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2291749A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266558A2 (fr) * 1986-10-07 1988-05-11 Roche Diagnostics GmbH 5-Alkylbenzimidazoles, leur procédé de préparation et médicaments les contenant
EP0882718A1 (fr) * 1995-12-28 1998-12-09 Fujisawa Pharmaceutical Co., Ltd. Derives du benzimidazole
US6420409B1 (en) 1997-06-27 2002-07-16 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
JP2007505942A (ja) * 2003-09-22 2007-03-15 エス＊バイオ プライベート リミティッド ベンズイミダゾール誘導体：製造及び医薬適用
US10626092B2 (en) 2016-05-02 2020-04-21 Mei Pharma, Inc. Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acrylamide and uses thereof
WO2021014172A1 (fr) * 2019-07-24 2021-01-28 Enterprise Therapeutics Limited Dérivés de pyridine utilisés comme modulateurs des canaux chlorure activés par le calcium

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335700A1 (fr) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
CN102911161A (zh) 2004-02-20 2013-02-06 贝林格尔.英格海姆国际有限公司 病毒聚合酶抑制剂
JP5015154B2 (ja) 2005-08-12 2012-08-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスポリメラーゼインヒビター

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266558A3 (fr) * 1986-10-07 1989-08-09 Roche Diagnostics GmbH 5-Alkylbenzimidazoles, leur procédé de préparation et médicaments les contenant
EP0266558A2 (fr) * 1986-10-07 1988-05-11 Roche Diagnostics GmbH 5-Alkylbenzimidazoles, leur procédé de préparation et médicaments les contenant
EP0882718A1 (fr) * 1995-12-28 1998-12-09 Fujisawa Pharmaceutical Co., Ltd. Derives du benzimidazole
EP0882718A4 (fr) * 1995-12-28 1999-08-04 Fujisawa Pharmaceutical Co Derives du benzimidazole
US6166219A (en) * 1995-12-28 2000-12-26 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
US6352985B1 (en) 1995-12-28 2002-03-05 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole compounds
US6420409B1 (en) 1997-06-27 2002-07-16 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
US7439258B2 (en) 2000-07-06 2008-10-21 Boehringer Ingelheim (Canada) Ltd Viral polymerase inhibitors
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
US6479508B1 (en) 2000-07-06 2002-11-12 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
US6794404B2 (en) 2000-07-06 2004-09-21 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
JP2007505942A (ja) * 2003-09-22 2007-03-15 エス＊バイオ プライベート リミティッド ベンズイミダゾール誘導体：製造及び医薬適用
US8551988B2 (en) 2003-09-22 2013-10-08 Mei Pharma, Inc. Benzimidazole derivatives: preparation and pharmaceutical applications
US9024029B2 (en) 2003-09-22 2015-05-05 Mei Pharma, Inc. Benzimidazole derivatives: preparation and pharmaceutical applications
US9402829B2 (en) 2003-09-22 2016-08-02 Mei Pharma, Inc. Benzimidazole derivatives: preparation and pharmaceutical applications
US9717713B2 (en) 2003-09-22 2017-08-01 Mei Pharma, Inc. Benzimidazole derivatives: preparation and pharmaceutical applications
US10201527B2 (en) 2003-09-22 2019-02-12 Mei Pharma, Inc. Benzimidazole derivatives: preparation and pharmaceutical applications
US10736881B2 (en) 2003-09-22 2020-08-11 Mei Pharma, Inc. Benzimidazole derivatives: preparation and pharmaceutical applications
US10626092B2 (en) 2016-05-02 2020-04-21 Mei Pharma, Inc. Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acrylamide and uses thereof
WO2021014172A1 (fr) * 2019-07-24 2021-01-28 Enterprise Therapeutics Limited Dérivés de pyridine utilisés comme modulateurs des canaux chlorure activés par le calcium

Also Published As

Publication number Publication date
FR2291749B1 (fr) 1978-07-28

Similar Documents

Publication Publication Date Title
FR2291749A1 (fr) Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique
FI851836A0 (fi) Foerfarande foer framstaellning av nya kompositioner.
ATE42951T1 (de) Thienylthiazolverbindungen.
ZA881726B (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6-carbozamides
FI833907A (fi) Naftalen-anti-psoriatiska substanser
ATE46332T1 (de) Spiro-imidazolidine als aldose-reduktaseinhibitoren.
CH614433A5 (en) Use of diaryloxytriazolyl-O,N-acetals and their salts for controlling fungi
ES2031514T3 (es) 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas.
DE69503905D1 (de) Peptidderivate mit metallopeptidasehemmender aktivität
ATE1240T1 (de) Alpha-aminophenylessigsaeurederivate zur verwendung bei der behandlung von entzuendungen sowie neue alpha-aminophenylessigsaeurederivate.
FI810103L (fi) Nya 2,3-dihydro-imidazo /1,2-b/ pyridazinderivat foerfarande foer deras framstaellning och deras terapeutiska anvaendning
FR2269938A2 (en) 5-Hydroxymethyl-3,4-diphenyl-1,2,4-triazoles - with anticholinergic, bronchodilator, antidepressant, analgesic, vasodilator activity, etc.
FR2269951A1 (en) 2H,4H-furo(2',3'-5-6)benzo(1,2-e)-1,3-oxazines - with analgesic, antiinflammatory cardiac analeptic, hypo- or hyper-tensive, and or spasmolytic activity
FR2381040A1 (fr) Derives de l'acide phenylpentanoique a usage therapeutique
DK52383D0 (da) Fremgangsmade til fremstilling af carbacyklinderivater
FR2239471A1 (en) Corynanthine hydrazides - as therapeutic agents
FR2292473A1 (fr) Derives de benzimidazole utiles en tant que medicaments
FR2251312A1 (en) 1-Propiophenone-2-phenyl propanol benzimidazoles - e.g. for use as vasodilators, respiratory analeptics, analgesics and hypotensives
IT1104703B (it) Derivati di 2,3-difenil-cromone loro procedimento di preparazione e loro applicazione terapeutica
FR2244514A1 (en) 1,2-Dihydroquinoline derivs - useful as anti-inflammatories
IT1097279B (it) Piridazinilidrazoni e procedimento per prepararli
JPS523081A (en) Preparation of sulfonylpyridazionones
IT1213288B (it) Composizione farmaceutica capace di suscitare effetti simili a quello del nitroprussiato sodico
NL7412696A (en) Gastric secretion inhibitory pyrid-2-yl-thioureas - for prevention and treatment of peptic ulcers
FR2282885A1 (fr) Composition pharmaceutique renfermant des pyridylthiourees

Legal Events

Date Code Title Description
ST Notification of lapse